WATSON 885 (Lisinopril 30 mg)

Pill imprint WATSON 885 has been identified as Lisinopril 30 mg.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; alport syndrome; coronary artery disease (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lisinopril

Imprint:

WATSON 885

Strength:

30 mg

Color:

Yellow

Shape:

Round

Availability:

Prescription only

Drug Class:

Angiotensin converting enzyme inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals

National Drug Code (NDC):

00591-0885

Inactive Ingredients:

silicon dioxide
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
corn starch
FD&C Yellow No. 5

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.